ArticleJournal of medical case reports2025
Two-stage treatment of cholecystobronchial fistula secondary to gallbladder perforation: a case report.
Article in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGallbladder perforation is a serious complication of acute cholecystitis. Among its rarest manifestations, cholecystobronchial fistula represents an exceptionally uncommon form of type III perforation and is frequently misdiagnosed due to its nonspecific presentation. A 67-year-old Chinese (East Asian) male presented with a chief complaint of cough and hemoptysis. His medical history was significant for nephrotic syndrome, for which he had been receiving long-term corticosteroid therapy. Imaging demonstrated cholelithiasis, a cholecystobronchial fistula, and a right-sided lung abscess. A staged treatment approach was implemented. Stage I involved ultrasound-guided percutaneous transhepatic gallbladder drainage for infection control. Following clinical stabilization, stage II consisted of laparoscopic cholecystectomy. Intraoperative findings confirmed spontaneous closure of the fistula. The patient achieved an uneventful recovery and remained recurrence-free during follow-up.
conclusionCholecystobronchial fistula typically results from chronic gallbladder inflammation. Prolonged corticosteroid use may obscure clinical manifestations, potentially delaying diagnosis. Contrast-enhanced computed tomography is essential for fistula identification, supplemented by bronchoscopic bilirubin or microbiological analysis. A staged minimally invasive approach enhances both safety and therapeutic efficacy. This report underscores the critical importance of multidisciplinary collaboration, precise imaging, and individualized surgical planning in the management of rare biliary fistulas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.